
    
      The research group is composed of patients over the age of 18 referred for unexplained
      elevation of liver enzymes and carry a single mutation in the ATP7B gene. After a washout
      period of 3 months these patients will be re-checked for liver enzymes and if high will
      receive zinc therapy at a dose of 300 mg / day for 6 months, after which the liver enzymes
      will be checked again.
    
  